Diabetes Drug a ‘Landmark Change’ for Intracranial Pressure

Few treatments exist for conditions associated with elevated intracranial pressure (ICP). Exendin-4, a GLP-1 receptor agonist used to treat diabetes, has shown promising results in rats with elevated ICP.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply